Science & Technology

Brookhaven Lab biologist Meng Xie and postdoctoral fellow Dimiru Tadesse with sorghum plants like those used in this study. Note that these plants are flowering, unlike those the scientists engineered to delay flowering indefinitely to maximize their accumulation of biomass. Photo by Kevin Coughlin/ BNL

By Daniel Dunaief

A traffic light turns green and a driver can make a left turn. Similarly, plants on one path can change direction when they receive a particular signal. In the case of the sorghum plant, the original direction involves growth. A series of signals, however, sends it on a different trajectory, enabling the plant to flower and reproduce, halting the growth cycle.

Brookhaven Lab biologist Meng Xie and postdoctoral fellow Dimiru Tadesse in the lab. Photo by Kevin Coughlin/ BNL

Understanding and altering this process could allow the plant to grow for a longer period of time. Additional growth increases the biomass of this important energy crop, making each of these hearty plants, which can survive in semiarid regions and can tolerate relatively high temperatures, more productive when they are converted into biomass in the form of ethanol, which is added to gasoline.

Recently, Brookhaven National Laboratory biologist Meng Xie teamed up with Million Tadege, Professor in the Department of Plant and Soil Science at Oklahoma State University, among others, to find genes and the mechanism that controls flowering in sorghum.

Plants that produce more biomass have a more developed root system, which can sequester more carbon and store it in the soil.

The researchers worked with a gene identified in other studies called SbGhd7 that extends the growth period when it is overexpressed.

Validating the importance of that gene, Xie and his colleagues were able to produce about three times the biomass of a sorghum plant compared to a control that flowered earlier and produced grain.

The plants they grew didn’t reach the upper limit of size and, so far, the risk of extensive growth  that might threaten the survival of the plant is unknown.

Researchers at Oklahoma State University conducted the genetic work, while Xie led the molecular mechanistic studies at BNL.

At OSU, the researchers used a transgenic sorghum plant to over express the flowering-control gene, which increased the protein it produced. These plants didn’t flower at all.

“This was a dramatic difference from what happens in rice plants when they overexpress their version of this same gene,” Xie explained in a statement. “In rice, overexpression of this gene delays flowering for eight to 20 days — not forever!”

In addition to examining the effect of changing the concentration of the protein produced, Xie also explored the way this protein recognized and bound to promoters of its targets to repress target expression.

Xie did “a lot of molecular studies to understand the underlying mechanism, which was pretty hard to perform in sorghum previously,” he said.

Xie worked with protoplasts, which are plant cells whose outer wall has been removed. He inserted a so-called plasmid, which is a small piece of DNA, into their growth medium, which the plants added to their DNA.

The cells can survive in a special incubation/ growth medium, enabling the protoplasts to incorporate the plasmid.

Sorghum plant. Photo by Kevin Coughlin/ BNL

Xie attached a small protein to the gene so they could monitor the way it interacted in the plant. They also added antibodies that bound to this protein, which allowed them to cut out and observe the entire antibody-protein DNA complex to determine which genes were involved in this critical growth versus flowering signaling pathway.

The flowering repressor gene bound to numerous targets. 

Xie and his BNL colleagues found the regulator protein’s binding site, which is a short DNA sequence within the promoter for each target gene.

Conventional wisdom in the scientific community suggested this regulator protein would affect one activator gene. Through his molecular mechanistic studies, Xie uncovered the interaction with several genes.

“In our model, we found that [the signaling] is much more complicated,” he said. The plant looks like it can “bypass each [gene] to affect flowering.”

Regulation appears to have crosstalk and feedback loops, he explained.

The process of coaxing these plants to continue to grow provides a one-way genetic street, which prevents the plant from developing flowers and reproducing.

These altered plants would prevent any cross contamination with flowering plants, which would help scientists and, potentially down the road, farmers meet regulatory requirements to farm this source of biomass.

Ongoing efforts

The targets he found, which recognize the short sequence of DNA, also appears in many other flowering genes.

Xie said the group’s hypothesis is that this regulator in the form of this short sequence of DNA also may affect flowering genes in other plants, such as maize and rice.

Xie is continuing to work with researchers at OSU to study the function of the numerous targets in the flowering and growth processes. 

He hopes to develop easy ways to control flowering which might include spraying a chemical that blocks flowering and removing it to reactive reproduction. This system would be helpful in controlling cross contamination. He also would like to understand how environmental conditions affect sorghum, which is work he’s doing in the lab. Down the road, he might also use the gene editing tool CRISPR to induce expression at certain times.

Honing the technique to pursue this research took about four years to develop, while Xie and his students spent about a year searching for the molecular mechanisms involved.

Rough beginning

Xie departed from his post doctoral position at Oak Ridge National Laboratory in March of 2020, when he started working at BNL. That was when Covid altered people’s best-laid plans, as he couldn’t come to the lab to start conducting his research for about six months. 

Born in Shanxi province in China, Xie and his wife Jingdan Niu live in Yaphank and have a two-year old son, Felix Xie.

When he was growing up, Xie was interested in math, physics, chemistry and biology. As an undergraduate in Beijing, Xie started to learn more about biology and technology, which inspired him to enter this field.

Biotechnology “can change the world,” Xie said.

Suffolk County Community College’s libraries and STEM departments held its annual STEM Day on each of its three campuses on April 10. The college’s STEM Day is now in its ninth successful year.

This dynamic annual event spotlights the ingenuity and talent of students and faculty engaged in the STEM disciplines at Suffolk. From experiments to impressive technology demonstrations, attendees were treated to a diverse range of presentations by students learning under the guidance and direction of their faculty advisors. The event program also allowed faculty members to feature the essence of their program disciplines and the approaches utilized in the college’s classes and labs.

“Each year, the underlying spirit of this event remains constant – fostering engagement and excitement for STEM disciplines among students and the wider community,” said Dr. Edward Bonahue, President, Suffolk County Community College.

One noteworthy aspect of STEM Day is its role in preparing students for future academic endeavors. Suffolk provides a unique, educational enrichment environment for students pursuing careers in the science, technology, engineering, and mathematics fields. As one example, through the National Science Foundation’s I-SUCCESS Program, the college sponsors 18 scholars annually with tuition and enhanced supports to increase their continued academic and career success in the STEM fields.

About Suffolk County Community College

Suffolk County Community College is the largest community college in the State University of New York (SUNY) system, enrolling approximately 21,000 students at its three campuses in Selden, Brentwood and Riverhead. Suffolk offers the Associate in Arts (A.A.), Associate in Science (A.S.), and Associate in Applied Science (A.A.S.) degrees, as well as a variety of certificate programs. Offering affordable college tuition, a highly respected Honors program, workforce training programs, extensive extracurricular activities, championship athletic teams, and numerous transfer programs, Suffolk is a first-choice college for Long Island students. Visit them online at sunysuffolk.edu.

Tobias Janowitz and Hassal Lee. Photo by Caryn Koza

By Daniel Dunaief

Before treatments for any kind of health problem or disease receive approval, they go through a lengthy, multi-step process. This system should keep any drugs that might cause damage, have side effects or be less effective than hoped from reaching consumers.

In the world of cancer care, where patients and their families eagerly await solutions that extend the quality and quantity of life, these clinical trials don’t always include the range of patients who might receive treatments.

Hassal Lee. Photo by Caryn Koza

That’s according to a recent big-picture analysis in the lab of Cold Spring Harbor Laboratory Professor Tobias Janowitz. Led by clinical fellow Hassal Lee, these researchers compared where clinical trials occurred with the population near those centers.

Indeed, 94 percent of United States cancer trials involve 78 major trial centers, which were, on average, in socioeconomically more affluent areas with higher proportions of self-identified white populations compared with the national average.

“We should test drugs on a similar population on which we will be using the drugs,” said Lee. In addition to benefiting under represented groups of patients who might react differently to treatments, broadening the population engaged in clinical trials could offer key insights into cancer. Patient groups that respond more or less favorably to treatment could offer clues about the molecular biological pathways that facilitate or inhibit cancer.

Janowitz suggested that including a wider range of patients in trials could also help establish trust and a rapport among people who might otherwise feel had been excluded.

The research, which Lee, Janowitz and collaborators published recently as a brief in the journal JAMA Oncology, involved using census data to determine the socioeconomic and ethnic backgrounds of patient populations within one, two and three hour driving distances to clinical trials.

The scientists suggested researchers and drug companies could broaden the patient population in clinical trials by working with cancer centers to enlist trial participants in potential life-extending treatments through satellite hospitals.

Project origins

This analysis grew out of a study Janowitz conducted during the pandemic to test the effectiveness of the gerd-reducing over-the-counter drug famotidine on symptoms of Covid-19.

Janowitz generally studies the whole body’s reaction to disease, with a focus on cancer associated cachexia, where patients lose considerable weight and muscle mass. During the pandemic, however, Janowitz, who has an MD and PhD, used his scientific skills to understand a life-threatening disease. He designed a remote clinical trial study in which participants took famotidine and monitored their symptoms.

While the results suggested that the antacid shortened the severity and duration of symptoms for some people, it also offered a window into the way a remote study increased the diversity of participants. About 1/3 of the patients in that population were African American, while about 1/4 were Hispanic.

Lee joined Janowitz’s lab in early 2022, towards the end of the famotidine study. 

“The diverse patient population in the remote trial made us wonder if commuting and access by travel were important factors that could be quantified and investigated more closely,” Janowitz explained.

Lee and Janowitz zoomed out to check the general picture for cancer clinical trials.

To be sure, the analysis has limitations. For starters, the threshold values for travel time and diversity are proof of concept examples, the scientists explained in their paper. Satellite sites and weighted enrollment also were not included in their analysis. The cost other than time investment for potential clinical trial participants could present a barrier that the researchers didn’t quantify or simulate.

Nonetheless, the analysis suggests clinical trials for cancer care currently occur in locations that aren’t representative of the broader population.

The work “leveraged freely available data and it was [Lee’s] effort and dedication, supported by excellent collaborators that we had, that made the study possible,” Janowitz explained.

Since the paper was published, Cancer Center directors and epidemiologists have reached out to the CSHL scientists.

Searching for clinical research

After Lee, who was born in Seoul, South Korea and moved to London when she was five, completed her MD and PhD at the University of Cambridge, she wanted to apply the skills she’d learned to a real-world research questions.

She found what she was looking for in Janowitz’s lab, where she not only considered the bigger picture question of clinical trial participation, but also learned about coding, which is particularly helpful when analyzing large amounts of data.

Lee was particularly grateful for the help she received from Alexander Bates, who, while conducting his own research in a neighboring lab in the department of Neurobiology at the MRC Laboratory of Molecular Biology in Cambridge, offered coding coaching.

Lee described Bates as a “program whiz kid.”

A musician who enjoys playing classical and jazz on the piano, Lee regularly listened to music while she was in the lab. Those hours added up, with Spotify sending her an email indicating she was one of the top listeners in the United Kingdom. The music service invited her to an interview at their office to answer questions about the app, which she declined because she had moved to the United States by then.

The top medical student at Cambridge for three years, Lee said she enhanced her study habits when she felt unsure of herself as a college student.

She credits having great mentors and supportive friends for her dedication to work.

Lee found pharmacology one of the more challenging subjects in medical school, in part because of the need to remember a large number of drugs and how they work.

She organized her study habits, dividing the total number of drugs she needed to learn by the number of days, which helped her focus on studying a more manageable number each day.

Lee will be a resident at Mt. Sinai Hospital later this year and is eager to continue her American and New York journey.

As for the work she did with Janowitz, she hopes it “really helps people think about maintaining diversity in clinical trials using data that’s already available.”

Cold Spring Harbor Laboratory’s Grace Auditorium, One Bungtown Road, Cold Spring Harbor hosts a lecture titled Tomatoes in Space on Wednesday, April 10 from 7 to 9 p.m. HHMI Investigator, and CSHL Director of Graduate Studies Zachary Lippman leads the audience on a captivating journey as he reveals how CRISPR gene-editing technology is shaping the future of agriculture.

From making crops grow in busy cities to reaching for the stars so plants can grow in space, Dr. Lippman’s lecture walks listeners through the importance of diversifying our agricultural system here on Earth, and beyond. Q&A will follow the lecture. Light refreshments will be served. Free but registration required at www.cshl/edu. For more information, call 516-367-8800.

Winners in the 3D printed category: pictured from left, Jashmin Futch of TFCU; third place winner Stella Bond, Bridgehampton School; second place winner Landon Tully, Accompsett Middle School; first place winner Srihas Mandava, Accompsett Middle School; and Robert Caradonna of BNL Photo by Jessica Rotkiewicz/Brookhaven National Laboratory

A big blue shark, an array of pirate ships, and a propeller-driven water bottle were among student-made magnetic levitation vehicles that floated down the tracks at the 2024 Maglev Competition hosted by the U.S. Department of Energy’s Brookhaven National Laboratory in Upton on March 20.

Students from middle schools across Long Island became engineers at the annual contest, designing and refining their maglev creations to log their fastest travel time. A total of 150 students from 10 local middle schools including Accompsett Middle School and Great Hollow Middle School of Smithtown submitted vehicles in hopes of earning top spots in eight categories judging speed and appearance.

The competition is inspired by technology pioneered by two Brookhaven Lab researchers, the late Gordon Danby and James Powell, who invented and patented superconducting maglev — the suspension, guidance, and propulsion of vehicles by magnetic forces.

“The Maglev Contest is unique in the way it provides students with an open environment to tinker, tweak, and test their vehicle designs in order to achieve the best possible outcome,” said competition coordinator Jonathan Ullmann, a senior education programs representative for the Lab’s Office of Educational Programs. “This process is very similar to how the scientists and engineers work on big research projects here at Brookhaven Lab.”

During the awards ceremony, the students heard from Robert Caradonna, a federal project manager at the DOE-Brookhaven Site Office, about his role in overseeing large design and construction of scientific research facilities including the current project to construct the Electron-Ion Collider (EIC) — a new discovery machine that physicists will use to explore the building blocks of matter — and the previous effort to construct the National Synchrotron Light Source II (NSLS-II), a DOE Office of Science user facility where interdisciplinary researchers explore materials.

Students use math, science, and technology principles to optimize the design of their vehicles. The competition day also brings out their creativity and resourcefulness on the fly: one student fixed their math homework to their vehicle to use as a sail on the contest’s wind-powered track; another student attempted to fill a disposable glove with air to propel their vehicle down a flat track after their original balloon broke.

“That’s what it’s all about — for them to troubleshoot and figure it out,” said David Driscoll, a technology teacher at Albert G. Prodell Middle School. “They’re learning to have patience, think through things, change things up, and make adjustments.”

Students who opted to compete in this year’s appearance categories went for unique and eye-catching designs that included a leek (the vegetable) used as a vehicle body, hand-painted artwork from a favorite show, and color-changing lights. A host of 3D-printed creations traveled down the tracks, too, including train cars, a racecar, and an intricate lizard.

This was the first year that the Bridgehampton School’s STEAM Team — a before-school club — entered 3D-printed vehicles into the competition after learning how to use 3D printers and a modeling program.

“We’ve been using MakerBot 3D printers and Tinkercad; the kids have been having a blast on it,” said Lou Liberatore, a fifth-grade teacher at Bridgehampton.

Mallory Dougherty, also a fifth-grade teacher at Bridgehampton, added: “We’re really excited to be in that category. They really picked up on it. They impressed us with how they were about to figure out how it all works.”

Congratulations to the following winners:

Speed categories

Self-propelled (balloon)

First place: Andrew Oliveri, Bay Shore Middle School; Second place: Ghaleb Rashid, Bay Shore Middle School; and Third place: Landon Wernersbach, Bay Shore Middle School

Self-propelled (other)

First place: Owen Huber, Bay Shore Middle School; Second place: Caleb Leichtman, Bay Shore Middle School; and Third place: Indigo O’Neill, Bay Shore Middle School

Electrified track

First place: Chase Harrison, Bay Shore Middle School; Second place: Jordan Patron, Bay Shore Middle School; and Third place: Ethan Rodriguez, Bay Shore Middle School

Wind power

First place: Jordyn Lusak, Albert G. Prodell Middle School; Second place: Brody Morgan, Great Hollow Middle School; and Third place: Alex Manessis, Accompsett Middle School

Gravity

First place: Jonah Maraglio, Albert G. Prodell Middle School; Second place: Eva Cabrera, Bay Shore Middle School; and Third place: Doris Lu, Great Neck South Middle School

Appearance categories

Futuristic

First place: Aylin Tucksonmez, Albert G. Prodell Middle School; Second place: Jeremy Schember, Great Hollow Middle School; and Third place: Alexander Radek, Great Hollow Middle School

Scale model

First place: Quentin Lennox, Marcus Chang, & Lucas Chang, Great Neck South Middle School; Second place: Owen Anderson, Albert G. Prodell Middle School; and Third place: Brendan D’Agostino, Berner Middle School

3D printed

First place: Srihas Mandava, Accompsett Middle School; Second place: Landon Tully, Accompsett Middle School; and Third place: Stella Bond, Bridgehampton School

From left, Juan Jimenez and Sanjaya Senanayake in front of CO2 and Methane Conversion Reactor Units in the Chemistry Division at Brookhaven National Laboratory. Photo by Kevin Coughlin/BNL

By Daniel Dunaief

If we had carbon dioxide glasses, we would see the gas everywhere, from the air we, our pets, and our farm animals exhale to the plumes propelled through the smokestacks of factories and the tail pipes of gas-powered cars.

Juan Jimenez. Photo by Kevin Coughlin/BNL

A waste product that scientists are trying to reduce and remove, carbon dioxide is not only a part of the photosynthesis that allows plants to convert light to energy, but it also can be a raw material to create usable and useful products.

Juan Jimenez, a postdoctoral researcher and Goldhaber Fellow at Brookhaven National Laboratory, has been working with carbon dioxide for the last 10 years, in his undergraduate work at CUNY City College of New York, for his PhD at the University of South Carolina and since he arrived at BNL in 2020. 

Jimenez contributed to a team led by engineers at the University of Cincinnati to create a way to improve the electrochemical conversion of this greenhouse gas into ethylene, which is an important ingredient in making plastics as well as in manufacturing textiles and other products.

University of Cincinnati Associate Professor Jingjie Wu recently published work in the journal Nature Chemical Engineering in which they used a modified copper catalyst to improve the electrochemical conversion of carbon dioxide into ethylene.

“I’m always looking out to collaborate with groups doing cutting edge research,” explained Jimenez, who spearheaded the research at the National Synchrotron Lightsource II. “Since the work on CO2 is a global concern we require a global team” to approach solutions.

Jimenez is fascinated with carbon dioxide in part because it is such a stable molecule, which makes reacting it with other elements to transform it into something useful energy intensive.

A modified copper catalyst helped convert more carbon dioxide, which breaks down into two primary carbon-based products through electrocatalysis, into ethylene, which has been called the “world’s most important chemical.”

“Our research offers essential insights into the divergence between ethylene and ethanol during electrochemical CO2 reduction and proposes a viable approach to directing selectivity toward ethylene,” UC graduate student Zhengyuan Li and lead author on the paper, said in a statement.

A previous graduate student of Wu, Li helped conduct some of the experiments at BNL.

This modified process increases the selective production of ethylene by 50 percent, Wu added.

The process of producing ethylene not only increases the production of ethylene, but it also provides a way to recycle carbon dioxide.

In a statement, Wu suggested this process could one day produce ethylene through green energy instead of fossil fuels.

Jimenez’s role

Scientists who want to use the high-tech equipment at the NSLS-II need to apply for time through a highly competitive process before experimental runs.

Jimenez led the proposal to conduct the research on site at the QAS and ISS beamlines.

Several of the elements involved in this reaction are expensive, including platinum, iridium, silver and gold, which makes them prohibitively expensive if they are used inefficiently. By using single atoms of the metal as the sites, these scientists achieved record high rates of reaction using the least possible amount of material.

The scientists at BNL were able to see the chemistry happening in real time, which validated the prediction for the state of the copper.

Jimenez’s first reaction to this discovery was excitement and the second was that “you can actually take a nap. Once you get the data you’re looking for, you can relax and you could shut your eyes.”

Working at NSLS-II, which is one of only three or four similar such facilities in the United States and one of only about a dozen in the world, inspires Jimenez, where he appreciates the opportunity to do “cutting edge” research.

“These experiments are only done a few times in the career of the average scientist,” Jimenez explained. “Having continuous access to cutting edge techniques inspires us to tackle bigger, more complicated problems.”

In the carbon dioxide research, the scientists drilled down on the subject, combining the scope of what could have been two or three publications into a single paper.

Indeed, Nature Chemical Engineering, which is an online only publication in the Nature family of scientific journals, just started providing scientific papers in the beginning of this year.

“Being part of the inaugural editions is exciting, specifically coming from a Chemical Engineering background” as this work was published along with some of the “leading scientists in the field,” said Jimenez.

New York state of mind

Born in Manhattan, Jimenez lived in Queens near Jamaica until he was 11. His family moved into Nassau County near the current site of the UBS Arena.

During his PhD at the University of South Carolina, Jimenez spent almost a year in Japan as a visiting doctoral student, where he learned x-ray absorption spectroscopy from one of the leading scientists in the field, Professor Kiyotaka Asakura. Based in Hokkaido University in Sapporo, Japan, Jimenez enjoyed touring much of the country.

A resident of Middle Island, Jimenez likes to run and swim. He enjoys cooking food from all over the world, including Spanish, Indian and Japanese cuisines.

As a scientist, he has the “unique luxury” of working with an international audience, he said. “If you are having lunch and you see someone eating amazing Indian food, you can talk to them, learn a bit about their culture, how they make their food, and then you can make it.”

As for his work, Jimenez explains that he is drawn to study carbon dioxide not just for the sake of science, but also because it creates a “pressing environmental need.”

He has also been looking more at methane, which is another potent greenhouse gas that is challenging to activate.

Ideally, at some point, he’d like to contribute to work that leads to processes that produce negative carbon dioxide use.

Jacob L Houghton, PhD, in his Stony Brook Cancer Center laboratory. Photo by John Griffin

Stony Brook University signs licensing agreement with Perspective Therapeutics

Image-guided radionuclide therapy uses radioactive molecules designed to specifically target and kill cancer cells while sparing non-cancerous tissues. This form of targeted therapy can be effective against cancer, but traditional methods for applying this therapy can also result in significant adverse effects related to off-target radiation toxicity. A team of Stony Brook University researchers developed a new method for image-guided radionuclide therapy that uses a two-step process with specially-modified antibodies to target the cancerous tumors, followed by a radioligand designed to bind specifically to the modified antibody.

Preliminary studies have shown that the approach can drastically reduce adverse effects while remaining extremely effective at targeting and killing the cancer cells. The promise of this technology has led to an exclusive licensing agreement with Perspective Therapeutics, Inc., headquartered in Seattle, WA.

The licensing agreement with Perspective Therapeutics is through the Research Foundation for State University of New York’s (SUNY), a private, non-profit,  education corporation that manages research administration and intellectual property for and on behalf of SUNY.

Nuclear imaging and targeted radionuclide therapy with biological molecules are a rapidly growing approach for the diagnosis, staging, and treatment of cancer and other pathologies such as inflammation and infection. Traditionally, the therapy has primarily been used in specific diseases such as thyroid cancer, bone cancer metastases, and neuroendocrine cancer. However, a major potential drawback of existing technologies is a resulting high radiation dose to healthy tissues from the combination of long-lived radionuclides and long biological half-life of the targeting molecules.

Stony Brook University radiology researchers Jacob L. Houghton, PhD, and Vilma I.J. Jallinoja, PhD, developed a new technology that overcomes these hurdles to more widespread use of radionuclide therapy. The platform involves using a small molecule that is labeled with a therapeutic radionuclide known as a radioligand, along with a modified monoclonal antibody – such as those used in immunotherapies to target cancer cells – in a two-step process. The platform enabled them to use the specificity of monoclonal antibodies to target cancer  and take advantage of a small molecule radioligand in a manner that retains the efficacy of the therapy while substantially improving the safety through a reduction in radiation toxicity.

Houghton, an Assistant Professor in the Department Radiology in the Renaissance School of Medicine (RSOM), and researcher in the Stony Brook Cancer Center, conducts research on targeted radionuclide therapy for diagnosing and treating cancer. He will continue to collaborate with scientists at Perspective Therapeutics as they further develop the technology. Jallinoja is no longer at Stony Brook.

“Our technology allows the use of such molecules for imaging and therapy while abrogating the concerns of radiation toxicity by using a pre-targeting technique which enables us to ‘label’ the biological molecule after it has been delivered to the target tissue and cleared from peripheral tissues,” explains Houghton.

Specifically, the pre-targeting radionuclide approach involves these steps: an antibody that has been modified to include an artificial binding group is administered to target to the tumor; then the radioligand carries the radionuclide to the tumor which binds specifically to the artificial binding group on the antibody. The radioligand rapidly accumulates in the tumor via this highly-specific interaction, and the unbound radioligand clears the body quickly. This process allows for optimal delivery of the radioactivity to the tumor, with little interaction with healthy tissue and organs.

This method differs from traditional approaches to targeted radionuclide therapy that directly attaches the radioactive payload to the targeting antibody, which can take days to accumulate in the tumor, leading to increased exposure to healthy tissues.

“By embracing a strategy that leverages the precision of monoclonal antibodies and the versatility of small molecules, Perspective is poised to redefine the landscape of radiation therapy,” says Thijs Spoor, Chief Executive Officer at Perspective Therapeutics. “One of our core missions as a company is to deliver safe and effective radiotherapies to patients.”

The team at Stony Brook University’s Intellectual Property Partners (IPP) worked to create the license with Perspective and develop a partnership to bridge new radiopharmaceutical technologies into eventual diagnostics and treatments.

“We are excited to partner with Perspective Therapeutics to advance this novel CB7-Adma pre-targeting platform toward clinical use. The combination of Perspective’s propriety radionuclide chelators and our pre-targeting platform has the potential to significantly improve clinical outcomes in a variety of cancer indications,” says Sean Boykevisch, PhD, Director of the IPP. “This partnership is a great example of how IPP works with Stony Brook inventors, helping them bridge their innovations with societal benefit in collaboration with industry partners.”

Perspective Therapeutics is a radiopharmaceutical development company that is pioneering the delivery of powerful radiation specifically to cancer cells via specialized targeting peptides. The Company is also developing complementary imaging diagnostics that incorporate the same targeting peptides. This “theranostic” approach  is designed to see the specific tumor and then treat it to potentially improve efficacy and minimize toxicity associated with cancer treatments.

 

Caption: Jacob L Houghton, PhD, in his Stony Brook Cancer Center laboratory.

Credit: John Griffin

From left, Mikala Egeblad and Xue-Yan He. Photo from Constance Brukin

By Daniel Dunaief

They both have left Cold Spring Harbor Laboratory, but the innovative research they did on Long Island and that they continue to do, is leaving its mark.

From left, Mikala Egeblad and Xue-Yan He at the American Association for Cancer Research (AACR) annual meeting in New Orleans, Louisiana in 2022. Photo from Xue-Yan He

When Xue-Yan He was a postdoctoral researcher in the lab of Mikala Egeblad, who was Associate Professor at CSHL, the tandem, along with collaborators, performed innovative research on mice to examine how stress affected the recurrence and spread of cancer in a mouse model.

In a paper published in late February in the journal Cancer Cell, He, who is currently Assistant Professor of Cell Biology & Physiology at Washington University School of Medicine in St. Louis, discovered that stress-induced neutrophil extracellular traps (NETs), which typically trap and kill bacteria, trigger the spread of cancer.

“The purpose of our study is to find out what stress does to the body” of an animal model of cancer, said He.

The data in mice demonstrated that targeting NETs in stressed animals significantly reduced the risk for metastases, He explained, suggesting that reducing stress should help cancer treatment and prevention. The researchers speculate that drugs preventing NET formation can be developed and used as new treatments to slow or stop cancer’s spread.

To be sure, this finding, which is encouraging and has generated interest among cancer scientists and neurobiologists, involved a mouse model. Any potential application of this research to the diagnosis and treatment of people will take considerably more effort.

“I want to stress that the evidence for the link between stress, NETs, and cancer is from mouse studies,” Egeblad explained. “We will need to design human studies to know for sure whether the link also exists for humans.”

Still, Egeblad hopes that eventually reducing stress or targeting NETs could be options to prevent metastatic recurrence in cancer survivors. “One major challenge is that a cancer diagnosis by itself is incredibly stressful,” she explained. The results of these experiments have attracted considerable attention in the scientific community, where “there is a lot more to learn!” 

Three part confirmation

When she was a postdoctoral researcher, He removed neutrophils from the mice using antibodies. Neutrophils, which are cells in the immune system, produce the NETs when they are triggered by the glucocorticoid stress hormone.

She also injected an enzyme called DNAse to destroy NETs in the test mice. The former CSHL postdoctoral researcher also used genetically engineered mice that didn’t respond to glucocorticoids.

With these approaches, the test mice developed metastasis at a much lower rate than those that had intact NETs. In addition, chronically stressed mice who didn’t have cancer had NETs that modified their lung tissue.

“Stress is doing something to prepare the organs for metastasis,” said He.

Linda Van Aelst, CSHL Professor and a collaborator on the study, suggested that this work validates efforts to approach mental health in the context of cancer.

“Reducing stress should be a component of cancer treatment and prevention,” Van Aelst said in a statement.

After He removed the primary tumor in the mouse models, the stressed mice developed metastatic cancer at a four-fold higher rate than the mice who weren’t stressed but who also previously had cancer.

The CSHL scientists primarily studied breast cancer for this work.

He appreciated the help and support from her colleagues at CSHL. “To really understand the mechanism” involved in the connection between stress and cancer, “you need a mouse model in the lab, an expert in neuroscience and an expert in the cancer field,” she said.

As a neuroscientist, Van Aelst offered suggestions and comments and helped He conduct behavioral tests to determine a mouse’s stress level. The work for this project formed the focus ofHe’s postdoctoral research, which started in 2016 and ended in 2023.

The link between stress and cancer is receiving increasing attention in the scientific community and has attracted attention on social media, He said.

CSHL “provided a great environment to perform all these experiments,” said He. The numerous meetings CSHL hosts and the willingness of principal investigators across departments made the lab “one of the best places” for a postdoctoral scientist.

“If you need anything from a neural perspective or a technical perspective, you can always find a collaborator” at CSHL, He added.

Born and raised in Nanjing, China, He enjoyed living on Long Island, visiting vineyards and trying to explore every state park. In the harbor, He caught blue crabs while her husband Chen Chen, who was a postdoctoral researcher at CSHL in the lab of Camila dos Santos, went fly fishing at Jones Beach.

In her current research, where she manages a lab that includes a senior scientist, a postdoctoral researcher and an undergraduate, He is extending the work she did at CSHL to colorectal cancer, where she is also analyzing how stress affects the spread of cancer.

“When you’re stressed, you can develop gastrointestinal problems, which is why I wanted to switch from breast cancer to colorectal cancer,” she said.

Extensions of the work

As for context for the research at CSHL, Egeblad wrote that doctors treating patients where the known risk of recurrence is high might use NETs in the blood as a biomarker.

The scientists think cancers that tend to metastasize to the liver, lung or spleen are the strongest candidates to determine the effect of NETs and stress on cancer.

“We have not seen any effects of targeting NETs for metastasis to the bone or the brain in our mouse model and similarly, the studies that have linked NETs to metastasis in human patients have mostly been cancer that has spread to the liver or the lung,” Egeblad said.

Egeblad appreciated the “fantastic job” He did on the work and described her former researcher as being “fearless.”

“She found that stress increased metastasis early in her project but it was a lot of work to discover it was the NETs that were responsible and to conduct studies to ensure that the results were applicable to different types of cancer,” Egeblad explained.

While the two researchers have gone to different institutions and are leading other lab efforts, Egeblad said she’d be happy to collaborate with her former student, who shares the same sense of humor.

Egeblad recalled how He ended her talks by telling the audience that her results showed that Egeblad should give her a “long vacation.”

“I think indeed that she has deserved one after all this work!” Egeblad offered.

Georgios Moutsanidis, Photo by Ram Telikicherla

By Daniel Dunaief

In the best of times, water provides a serene background, offers an escape from searing summer heat, serves as a livelihood for the fishing industry, and supports a range of aquatic life that shimmers just below the surface.

In the worst of times, that same water can threaten communities that line coasts, bringing a powerful surge of destructive force that takes lives and destroys homes, buildings and infrastructure.

Recently, Georgios Moutsanidis, Stony Brook University Assistant Professor in the department of Civil Engineering, received a $500,000, five-year Faculty Early Career Development grant from the National Science Foundation to conduct research that could increase the resilience of coastal structures.

Rigoberto Burgueño, who is the chairman of the Civil Engineering department and who helped recruit Moutsanidis to Stony Brook in 2020, is pleased with the recognition from the NSF.

It is “one of the highest achievements for an individual investigator in terms of their potential as future leaders in their field and future mentors and teachers,” Burgueño said. The prestige from the award “will provide opportunities and bigger audiences to communicate his findings and his work.”

Amid climate change, the need for efforts to improve resilience from a range of water-driven forces increases, as rising sea levels encroach on coastlines and stronger storms driven by higher ocean temperatures threaten buildings and infrastructure.

“What we are trying to do with this project is to develop state-of-the-art computational tools that engineers and other researchers will use to incorporate in their work and study the resilience of structures against extreme hydrodynamic events” such as storm surges and tsunamis, said Moutsanidis.

Engineers, city planners and builders have used what Moutsanidis described as mostly outdated empirical models to test the resilience of structures. Moutsanidis, however, hopes to enhance those models by taking a physics-based numerical approach to understanding the damage a surge of water could do to various structures.

Moutsanidis is using established and well-known equations. He will contribute to solving them more accurately and efficiently.

Other models “could simulate water hitting a structure, but they were unable to capture the detailed response of the structure, with cracks, fractures, fragmentation and collapse,” Moutsanidis said. He hopes the new computational methods he will develop will predict the type and extent of damage more accurately.

The model he plans to create, with the help of graduate students he will hire who will use new high-performance computers he expects to use the funds to purchase, can address site-specific features of an area that would affect the likely speed, amount and force of any water surge.

Burgueño described Moutsanidis as being “at the forefront of very advanced computational simulations that take into account interactions of water with a structure.”  

By generating better estimates of the actual loads imposed on a structure, “we will be better prepared as engineers to either strengthen existing structures or to design future ones better,” Burgueño said.

Checking his work

While the information he’s using to construct these models relies on physics and deploys established equations, the Stony Brook Assistant Professor and his students will perform verification and validation. They will compare their results with existing experimental data and other computational approaches.

In addition, Moutsanidis’s lab will conduct experiments in a flume, which is a water tank in which he can vary the amount and speed of water approaching models of coastal communities. With a high-speed camera, he can evaluate how these simulated structures respond. In buildings that might collapse or fracture, he can test a slightly different fortified design, run a similar analysis and determine if the modifications led to a better outcome.

At this point, Moutsanidis has completed a proof of concept article in the journal Engineering with Computers, where he demonstrated the idea and the equations he’s solving. He hopes to produce a useful package that engineers and the public can use within the next four to five years, which he will release through an open source platform such as GitHub.

Moutsanidis is “very eager to start this work” as storm surges, flooding and tsunamis threaten coastal communities every year.

Larger context and other projects

In the bigger picture, Moutsanidis seeks to use computational methods and software to solve problems of engineering driven by physics. He has also worked in the aerospace community, studying the interaction of solids with hypersonic flow.

The goal is to “design more efficient aerospace vessels” that can withstand high temperatures and pressure as they travel five times the speed of sound or more, he said. The temperature is so high that the air undergoes a chemical reaction.

Moutsanidis has also worked with the impact of blast waves on structures, simulating the response to the shock wave or blast.

The goal is to make structures “more resilient or resistant to extreme events” such as a terrorist attack or an accident that triggers an explosion.

From Karditsa to Queens

Born and raised in a small town in the center of Greece called Karditsa, Moutsanidis is the son of two engineers. “In my early childhood, I was influenced by them, but I chose a different engineering path,” he said.

Moutsanidis, who completed postdoctoral research at Brown University before joining Stony Brook, lives in Queens. 

Moutsanidis is impressed with the students at Stony Brook, whom he described as “very engaged.” As for his work, he explained that his field is “quite competitive” and he was surprised and pleased to receive this award.

This graphic summarizes shifts in public attitudes about AI, according to the Stony Brook-led survey. Image by Jason Jones

A Stony Brook University study suggests that on average, U.S. adults have gained confidence in the capabilities of AI and grown increasingly opposed to extending human rights to advanced AI systems.

In 2021, two Stony Brook University researchers – Jason Jones, PhD, Associate Professor in the Department of Sociology, and Steven Skiena, PhD, Distinguished Teaching Professor in the Department of Computer Science – began conducting a survey study on attitudes toward artificial intelligence (AI) among American adults. Some of their recent findings, published in the journal Seeds of Science, show a shift in Americans’ views on AI.

The researchers compared data collected from random, representative samples in 2021 and 2023 to determine whether public attitudes toward AI have changed amid recent technological developments – most notably the launch of OpenAI’s ChatGPT chatbot in late 2022. The new work builds on previous research into how AI is perceived in society, by way of the Jones-Skiena Public Opinion of Artificial Intelligence Dashboard and similar survey studies conducted with varying demographics.

The new study sampled two unique groups of nearly 500 Americans ages 18 and above, one of which was surveyed in March 2021 and the other in April 2023. Participants shared their opinions on the achievability of constructing a computer system able to perform any intellectual task a human is capable of, whether such a system should be built at all, and/or if that system – referred to as Artificial General Intelligence (AGI) – should be afforded the same rights as a human being.

Google Surveys was originally used as the platform for this research due to its capability of delivering random, representative samples.

“What we truly wanted to know was the distribution and average of public opinion in the U.S. population,” says Jones, co-author and also a member of Stony Brook’s Institute for Advanced Computational Science (IACS). “A random, representative sample is the gold standard for estimating that in survey research. Google shut down their Google Surveys product in late 2022, so we used another platform called Prolific to do the same thing for the second sample.”

Once the samples were collated, a statistically significant change in opinion was revealed regarding whether an AGI system is possible to build and whether it should have the same rights as a human.

In 2023, American adults more strongly believed in the achievability of AGI, yet were more adamantly against affording such systems the same rights as human beings. There was no statistically significant change in public opinion on whether AGI should be built, which was weakly favored across both samples.

Jones and Skiena stress that more studies must be conducted to better understand public perceptions of artificialintelligence as the technology continues to grow in societal relevance.

They will repeat the survey this spring with the same methods used in 2023 with the hope of  building further on their findings.